SpringWorks Therapeutics, Inc. short interest in 2022
In 2022, SpringWorks Therapeutics, Inc.'s disclosed short interest ran from 5.67% of shares outstanding on 14 Jan 2022 to 18.35% on 30 Dec 2022, a change of +12.68 percentage points. The year's high was 24.80% on 29 Jul 2022 and its low 5.67% on 14 Jan 2022, averaging 15.53% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 21.68 days on 29 Jul 2022. Full history: SpringWorks Therapeutics, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025
2022 in figures
- Start of year
- 5.67% (14 Jan 2022)
- End of year
- 18.35% (30 Dec 2022)
- Change
- +12.68 pp
- High
- 24.80% (29 Jul 2022)
- Low
- 5.67% (14 Jan 2022)
- Average
- 15.53%
- Highest days to cover
- 21.68 (29 Jul 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 5.67% | 4.95 | |
| 31 Jan 2022 | 7.01% | 7.04 | |
| 15 Feb 2022 | 7.80% | 12.42 | |
| 28 Feb 2022 | 7.68% | 10.33 | 10-K filed, results (8-K) |
| 15 Mar 2022 | 7.88% | 9.12 | |
| 31 Mar 2022 | 8.71% | 11.01 | |
| 14 Apr 2022 | 10.02% | 10.97 | |
| 29 Apr 2022 | 11.75% | 11.05 | |
| 13 May 2022 | 12.36% | 9.16 | 10-Q filed, results (8-K) |
| 31 May 2022 | 15.06% | 2.70 | |
| 15 Jun 2022 | 21.54% | 7.62 | |
| 30 Jun 2022 | 23.12% | 8.05 | |
| 15 Jul 2022 | 24.01% | 15.98 | |
| 29 Jul 2022 | 24.80% | 21.68 | |
| 15 Aug 2022 | 18.79% | 7.28 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 17.99% | 12.73 | |
| 15 Sep 2022 | 17.10% | 7.28 | |
| 30 Sep 2022 | 19.89% | 10.00 | |
| 14 Oct 2022 | 20.76% | 15.29 | |
| 31 Oct 2022 | 17.71% | 16.30 | |
| 15 Nov 2022 | 19.40% | 13.27 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 18.61% | 20.02 | |
| 15 Dec 2022 | 16.62% | 15.67 | |
| 30 Dec 2022 | 18.35% | 12.18 |
See also: SpringWorks Therapeutics, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.